Challenges Ahead for Specialty Pharmacy

Video

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Image credit: Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Related Content
Biosimilar, Humira | Image Credit: lexiconimages - stock.adobe.com

Patient Affordability Program for Adalimumab Biosimilar Is Launched at GoodRx

Ashley Gallagher, Associate Editor
July 25th 2024
Article
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

July 25th 2024
Podcast
FDA Approval | Image Credit: outchill - stock.adobe.com

FDA Approves Cerliponase Alfa for Expanded Indication of CLN2 Disease

Ashley Gallagher, Associate Editor
July 24th 2024
Article
Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

July 12th 2024
Podcast
Coagulation Factor VIII, FVIII, an essential blood-clotting protein, also known as anti-hemophilic factor, AHF, 3D illustration

Intravenous Immunoglobulin Temporarily Improves Bleeding in Patients With Acquired Von Willebrand Syndrome

Luke Halpern, Assistant Editor
July 24th 2024
Article
Antibodies that cause autoimmune diseases -- Image credit: Love Employee | stock.adobe.com

Study Results Indicate Potential Method of Reversing Lupus, Opening Doors to Treatment

Gillian McGovern, Assistant Editor
July 22nd 2024
Article